Skip to main content
Free trial

Ask AI to review this stock

Copy the prompt to get recent events, historical reactions, and a short research brief.

Tell your AI:

Help me set up FinLab and analyze VCYT Veracyte, Inc.. Please read: https://finlab.finance/en/setup?stock=VCYT

No install, write strategies with AI

VCYT

Veracyte, Inc. Healthcare As of 2026-07-22 Updated daily after market close

steady quality, premium valuation.

2 active signals
Top-quintile 6-month momentum Filed revenue acceleration
This page refreshes daily after the close. Add Veracyte, Inc. to your watchlist to track signal changes on your next visit.
Valuation 31Quality 68Growth 81Momentum 94Risk / liquidity 55

Is Veracyte, Inc. a buy? Fundamentals and valuation first

  • Quality is above average. Operating margin sits near the 62th percentile. TTM ROE is about 6.5%.

  • Valuation is expensive. TTM P/E is in the 91th percentile, above most peers.

  • Recent volatility is elevated. 60-day annualized volatility is in the 71th percentile. Average 20-day dollar volume is about $72.4M.

  • Signals are active now. Top-quintile 6-month momentum, Filed revenue acceleration currently holds; the tables below show what followed in this stock’s own history.

Historical evidence

Signals active now

Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.

Top-quintile 6-month momentum

Active · now 82.90816326530613%

The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.

18 historical occurrences (since 2016-09-13)
Average forward return after Top-quintile 6-month momentum。20-day: Win 41.2%, Sample 17, Median -1.14%, Excess -0.46%, Beat mkt rate 47.1%；60-day: Win 64.7%, Sample 17, Median +9.63%, Excess -0.29%, Beat mkt rate 52.9%；120-day: Win 58.8%, Sample 17, Median +16.17%, Excess +8.46%, Beat mkt rate 52.9%

120 days after: historical avg +19.15%

20-day +2.46%
60-day +5.95%
120-day +19.15%
20-day
60-day
120-day
Win
41.2%
64.7%
58.8%
Sample
17
17
17
Median
-1.14%
+9.63%
+16.17%
Excess
-0.46%
-0.29%
+8.46%
Beat mkt rate
47.1%
52.9%
52.9%

Over 17 occurrences, 120-day forward avg gained 19.15%, beat the market by 8.46 pts; win rate 58.8%.

Filed revenue acceleration

Active · now 16.907894594868722%

TTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.

14 historical occurrences (since 2018-05-01)
Average forward return after Filed revenue acceleration。20-day: Win 71.4%, Sample 14, Median +11.54%, Excess +7.14%, Beat mkt rate 64.3%；60-day: Win 69.2%, Sample 13, Median +16.5%, Excess +12.28%, Beat mkt rate 69.2%；120-day: Win 53.8%, Sample 13, Median +7.87%, Excess +18.04%, Beat mkt rate 53.8%

120 days after: historical avg +19.6%

20-day +8.05%
60-day +13.17%
120-day +19.6%
20-day
60-day
120-day
Win
71.4%
69.2%
53.8%
Sample
14
13
13
Median
+11.54%
+16.5%
+7.87%
Excess
+7.14%
+12.28%
+18.04%
Beat mkt rate
64.3%
69.2%
53.8%

Over 13 occurrences, 120-day forward avg gained 19.6%, beat the market by 18.04 pts; win rate 53.8%.

Market-wide momentum baseline

Across 96,543 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.32%, a 58.2% positive-return rate, and +2.96 percentage points of average excess return versus the S&P 500.

Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).

Signals not active now

Inactive signals still show the stock-specific historical forward-return distribution for context.

52-week adjusted-price high

Pending

Adjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.

18 times historically; 60-day forward avg +16.69%, win rate 64.7%, beating the market by +12.36 pts on average.

EPS surprise beat

Pending

Reported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.

31 times historically; 60-day forward avg +11.39%, win rate 70%, beating the market by +7.16 pts on average.

Method and limits

  • Returns use us_price:adj_close, adjusted for splits and dividends where available.
  • Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
  • Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
  • The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
  • Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
  • Overlapping event windows are descriptive distributions, not independent samples.

This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.